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Abstract
According to the cognitive neuropsychological hypothesis of antidepressant action, the onset of sub-
jectively experienced therapeutic eﬀects to treatment is preceded by favourable changes in psychological
functioning that can be measured by implicit methods. The aim of this study was to examine additional
data to explore this hypothesis in an intention-to-treat repetitive transcranial magnetic stimulation (rTMS)
study targeting the right parietal cortex. Changes in depression scores from baseline and the sensitivity for
recognizing emotional facial expressions were studied in 28 patients with depressive disorder receiving
ten sessions of real (n=14) or sham (n=14) rTMS treatments in a double-blind, sham-controlled design.
In the patient group results showed signiﬁcantly higher sensitivity for recognizing angry facial ex-
pressions in response to receiving real compared to receiving sham rTMS treatment. Overall mood im-
provement was similar across real and sham rTMS treatments. However, the sensitivity for recognizing
angry facial expressions was correlated to the percentage decrease in depression scores. These results
provide the ﬁrst preliminary support for the cognitive neuropsychological hypothesis of antidepressant
action in rTMS treatment.
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Introduction
According to the cognitive neuropsychological hy-
pothesis of antidepressant action, the onset of thera-
peutic eﬀects to treatment is preceded by changes
in psychological functioning (Harmer et al. 2009a,
Harmer, 2010). Changes in cognitive and emotive
processes associated with the neurophysiological
action of treatment are usually not consciously ac-
cessible to the patient or directly observable by others,
but nonetheless they may reveal antidepressant ac-
tion at an early stage of treatment. Single adminis-
trations of the antidepressant agents reboxetine and
citalopram have, for instance, been shown to reduce
biases for negative information and enhance the pro-
cessing of positive information without an immediate
eﬀect on mood (Harmer et al. 2009b). Similar eﬀects
have been observed in non-invasive brain stimu-
lation studies. Single administrations of 1-Hz slow-
frequency repetitive transcranial magnetic stimulation
(rTMS) have demonstrated decreased attentional
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responses to fearful faces (van Honk et al. 2002),
increased attentional responses to angry faces
(d’Alfonso et al. 2000) and improved memory per-
formance for happy faces (Schutter & van Honk,
2006). Notably, in all cases, no changes in mood were
observed.
In the past 15 yr rTMS over the frontal cortex has
been explored as an alternative way to treat depressive
disorder. Recent meta-analytical studies indicate that
rTMS reaches similar antidepressant eﬃcacy as sev-
eral registered antidepressant drugs (Demitrack &
Thase, 2009 ; Schutter, 2009, 2010). Despite being
equally eﬀective as antidepressants, the clinical rel-
evance of these eﬀects appears to be moderate. Hence,
the need for additional research exploring novel
strategies to optimize therapeutic eﬃcacy (Herrmann
& Ebmeier, 2006; Schutter & van Honk, 2005).
Evidence for possible antidepressant working of
rTMS applied to the right parietal cortex was found in
a sham-controlled study by van Honk et al. (2003). In
this study, a signiﬁcantly increased vigilant response
to facial anger accompanied decreases in self-reported
depressive mood, following a single 20-min session
of 2-Hz rTMS to the right parietal cortex in healthy
volunteers. The combination of more vigilant re-
sponsiveness to facial anger and reduced depressive
mood may indicate increased approach-related mo-
tivation (Depue & Iacono, 1989 ; Putman et al. 2004).
These ﬁndings led us to perform a double-blind, sham-
controlled study wherein, for the ﬁrst time, we ex-
plored the antidepressant eﬀects of 10 sessions of 2-Hz
rTMS over the right parietal cortex in 34 patients
(Schutter et al. 2009). Despite the larger partial anti-
depressant response observed in the real rTMS con-
dition, we did not ﬁnd a main eﬀect of treatment on
the percentage change in depression scores measured
with the 17-item Hamilton Depression Rating Scale
(HAMD17). However, we were able to collect and
analyse additional behavioural data on the sensitivity
for recognizing emotional facial expressions in a sub-
set of 28 patients after the ﬁnal treatment session,
which allowed us to examine the cognitive neuro-
psychological hypothesis of antidepressant action in
rTMS treatment.
In keeping with the cognitive neuropsychological
hypothesis of antidepressant action with data on
happy facial expressions (Harmer et al. 2009b ; Schutter
& van Honk, 2006) and our previous ﬁndings on angry
facial expressions (d’Alfonso et al. 2000; van Honk
et al. 2003) we hypothesized that the antidepressant
eﬀects of 2-Hz rTMS over the right parietal cortex
would be manifested by increased sensitivity to both
angry and happy facial expressions.
Methods
Participants
Twenty-eight of the thirty-four in-patients and out-
patients involved in clinical trial NTR1279 with a
primary diagnosis of depressive disorder according
to DSM-IV-TR criteria (APA, 2000) and a score ofi15
on HAMD17 were included in this follow-up analysis.
Current depressive disorder was conﬁrmed by the
Structured Clinical Interview for DSM-IV, Research
Version (SCID-I ; First et al. 1996). Real (n=14) and
sham (n=14) treatment groups did not diﬀer in age,
sex, medication and baseline HAMD17 scores (Table 1).
History of seizures, neurological conditions, metal
objects in or around the body that cannot be removed
(i.e. cochlear implant, surgical clips, piercings and
cardiac pacemaker), heart disease, pregnancy, drug
and alcohol abuse were considered exclusion criteria.
Antidepressant and hypnotic medication had been
stable for at least 6 wk and 2 wk, respectively, prior to
the study, and were kept constant during treatment.
All participants received written and verbal infor-
mation on the study and written informed consent
was obtained. The study was in accordance with the
Declaration of Helsinki and approved by the medical
ethics committee of Free University Medical Center
and St Lucas Andreas Hospital, Amsterdam, The
Netherlands.
Emotional facial recognition task
The sensitivity for recognizing facial expressions
was measured with a task adapted from Montagne
et al. (2005) that used morphed images from neutral
face (0% emotion) to full-blown expression (100%
emotion). Stimuli were taken from four actors (two
male, two female) who each posed a facial expression
Table 1. Demographic and clinical characteristics
rTMS treatment
characteristics
Real
(n=14)
Sham
(n=14)
p
valuea
Age, mean¡S.D., yr 44¡12 46¡13 0.69b
Female/Male, n 10/4 6/8 0.25c
Medication, n 10 9 1.00c
Baseline HAMD17
d,
mean¡S.D.
21¡4 21¡5 0.93b
a Two-tailed.
b Analysis of variance.
c Fisher’s exact probability test.
d 17-item Hamilton Depression Rating Scale.
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(i.e. neutral, anger, disgust, fear, happiness, sadness,
surprise) in frontal view. These facial expressions were
used to create short video clips that incrementally
increase the degree of emotional expression in 10%
steps (e.g. from neutral to anger). First, participants
viewed the video clips running from neutral to 20%
expression of all six emotional expressions by all four
actors in random order. Next, the same procedure
was applied for 30%, 40% and so on, until the ﬁnal
sequence of clips in which the neutral face changed
into the full-blown expression (100%). There were
216 trials that were preceded by six practice trials. In
each trial participants were required to make a forced
choice, without time restriction, between one of six
emotional expression labels that were shown on the
computer screen. For each emotion, an average sensi-
tivity scorewas computed on the basis of theminimum
degree of emotional expression needed to correctly
identify the emotional expression of the four actors
with 100% accuracy.
Transcranial magnetic stimulation (TMS)
TMS was performed using a high-frequency Magpro
Dantec magnetic stimulator with a MCF-B65 ﬁgure-
of-eight coil (Medtronic, Denmark). At the start of
the ﬁrst session individual motor threshold (MT) of
the right hemisphere was established using the visual
twitch method to determine the ﬁxed stimulation
intensity (mean¡S.D.) (Pridmore et al. 1998), MTreal
[76.2¡16.5 dI/dt (A/s)] and MTsham [84.8¡17.7 dI/dt
(A/s)]. Over the course of 2 wk patients received
ten 20-min sessions of 2-Hz rTMS at 90% MT (i.e. 2400
pulses per session). Parameters were selected based on
prior research showing that eﬀects of rTMS on cortical
excitability stabilize at 1600 pulses (Maeda et al. 2000)
and clinical evidence indicating that the magnitude
of the eﬀects depends on the number of pulses
(Touge et al. 2001). The rationale for applying rTMS at
subthreshold intensity is based on previous ﬁndings of
intensity-dependent increases of brain activity in local
and distal sites (Speer et al. 2003). Here, we used low-
intensity stimulation in an attempt to keep the eﬀects
restricted to the right parietal cortex. These parameter
settings have proved successful in a related rTMS
study in which reductions in phenomenological,
physiological and attentional indices of depressive
mood were found (van Honk et al. 2003).
Stimulation occurred over the P4 electrode site
according to the International 10–20 EEG system
targeting the right parietal cortex. The coil was held
tangentially to the scalp with the handle pointing to
the back and oriented away from the coil’s midline
at 45x. For sham stimulation a specially designed
ﬁgure-of-eight coil was used. This coil mimics the
sensation and sound of real rTMS, but prevents the
magnetic ﬁeld from reaching the target tissue through
interception by a built-in permalloy shield plate
(MC-P-B70, Medtronic, Denmark). Contact between
the physician applying rTMS and the patient was
kept to a minimum. Stimulation parameters and pro-
cedure were in accordance with safety guidelines
(Wassermann, 1998).
Procedure
Patients were randomly allocated to receive either
real or sham rTMS treatment on 10 consecutive work-
ing days (i.e. 2 wk) via sealed envelopes opened im-
mediately before the start of the ﬁrst treatment by the
clinician administering rTMS. Prior to entering the
study the patient underwent standard clinical, psy-
chiatric and laboratory tests and was screened for
contraindications to rTMS. Clinical assessment was
repeated after the ﬁnal treatment session. Depression
scores were acquired with HAMD17 at baseline and
after the ﬁnal treatment session. The emotional facial
recognition task was administered immediately after
the ﬁnal clinical assessment. Last, patients were asked
to indicate whether they had received real or sham
treatment. All ratings and tests were performed by
trained researchers blind to the actual treatment.
Statistical analyses
A binomial test was performed to check that patients
had remained blind to treatment. One-way analyses
of variance (ANOVA) were performed to test the
diﬀerence between real and sham rTMS treatments
on percentage change from baseline on HAMD17
scores and percentage sensitivity for the recognition of
emotional facial expressions. A Pearson’s correlation
was performed to examine the relationship between
percentage change from baseline on the HAMD17
scores and percentage sensitivity for the recognition of
emotional facial expressions. For all tests, a two-tailed
signiﬁcance level of 0.05 (uncorrected) was applied.
Results
Treatment was well tolerated by the patients. A bi-
nomial test demonstrated that blinding of treatment
condition was successful (p>0.5). The percentage
reduction from baseline on HAMD17 scores (mean¡
S.E.M) did not diﬀer between real (20¡8.8%) and sham
(8¡7.9%) rTMS treatments [F(1, 27)=1.00, p=0.33],
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showing that 10 sessions of 2-Hz rTMS over the
right parietal cortex did not yield signiﬁcant im-
provements on depression severity (cf. Schutter et al.
2009) (Fig. 1).
In contrast, signiﬁcant higher sensitivity (i.e. lower
percentage) for the recognition of angry facial ex-
pressions was observed in the real (42.3¡4.2%), com-
pared to the sham (60.7¡6.4%) rTMS treatments
[F(1, 27)=5.76, p=0.02]. The diﬀerence between real
(39.5¡5.8%), and sham (29.3¡2.2%) rTMS treatments
for the sensitivity of happy facial expressions did not
reach statistical signiﬁcance [F(1, 27)=2.73, p=0.11].
Sensitivity for the other facial expressions was not
statistically diﬀerent between real and sham rTMS
treatments (all p values>0.35) (Fig. 2).
Finally, a signiﬁcant correlation between percentage
change from baseline on the HAMD17 scores and sensi-
tivity for angry facial expressions was observed
[r(26)=0.51, p=0.005] (Fig. 3), indicating that the per-
centage reduction on HAMD17 scores from baseline
was associated with increased sensitivity for recog-
nition of angry facial expressions. Percentage re-
duction on HAMD17 scores did not correlate with the
sensitivity for the other emotional facial expressions
(all p values>0.30).
Discussion
The aim of this study was to examine whether the
neuropsychological hypothesis of antidepressant ac-
tion has potential in rTMS treatment. This hypothesis
states that prior to therapeutic onset positive eﬀects of
treatment can already be observed at the information
processing level (Harmer et al. 2009a ; Harmer, 2010).
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Fig. 1. No signiﬁcant baseline-corrected change in 17-item
HamiltonDepressionRating Scale (HAMD17) scores following
10 sessions of 2-Hz rTMS to the right parietal cortex.
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Fig. 2. Sensitivity for recognition of emotional facial
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rTMS to the right parietal cortex. * p=0.02 (two-tailed).
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Fig. 3. Percentage reductions on Hamilton Depression
Rating Scale (HAMD17) scores is associated with increased
sensitivity (i.e. lower percentage) for angry facial expressions
(n=28). Signiﬁcantly lower percentages on the recognition
of angry facial expressions in the real vs. sham rTMS
treatment groups suggest that the sensitivity of angry facial
expressions may index changes in psychological function
indicative for an antidepressant eﬀect.
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Our results showed signiﬁcantly higher sensitivity
in recognizing angry facial expressions following
10 sessions of real vs. sham 2-Hz rTMS to the right
parietal cortex. Despite observing an overall improve-
ment in mood, no main eﬀect of treatment was found.
Furthermore, the sensitivity for recognizing angry
facial expressions was correlated to the percentage
decrease in HAMD17 scores, indicating that the sensi-
tivity for the angry face may capture aspects of anti-
depressant action. This latter ﬁnding would be in
accord with a recent study in elderly depressed
patients demonstrating improvements in mood and
memory performance for angry facial expressions
following antidepressant therapy with escitalopram
(Savaskan et al. 2008). As mentioned earlier, heigh-
tened sensitivity for angry facial expressions has been
interpreted as a behavioural sign of increased
approach-related motivation (Putman et al. 2004), a
condition which is typically reduced or absent in pa-
tients suﬀering from depressive disorder (Depue &
Iacono, 1989). According to the integrative model of
mood based on fear and anger traits by Lara et al.
(2006), anger is conceptually related to appetitive im-
pulsivity, drive, pleasure, aggressive behaviour, goal-
directed behaviour, and dominance. Previous research
has shown relationships between reduced cortical
responses to anger-evoking events and diminished
approach-related motivation as a possible vulner-
ability factor for depression symptoms (Harmon-Jones
et al. 2002). In agreement, a functional magnetic
resonance imaging study has shown reduced brain
activation in response to angry facial expressions in
major depressive disorder (MDD) patients (Lee et al.
2008). Interestingly, the processing of angry facial
expressions has been linked to dopaminergic activity
(Lawrence et al. 2007), providing an indirect neuro-
chemical link between MDD and anger processing
(Dunlop & Nemeroﬀ, 2007). Finally, there is some
evidence suggesting that antidepressant medication
may have some anger-facilitating eﬀects as paroxetine
has been found to promote novelty-seeking in patients
with social phobia (Allgulander et al. 1998).
Evidence for a role of the parietal cortex in the
processing of angry facial expressions and possibly
depression was found in an earlier study, which
showed that vigilant attention for angry facial ex-
pressions was associated with reduced electrocortical
activity recorded over the right parietal lobe (Schutter
et al. 2001).
In agreement, as previously noted in a single-blind,
sham-controlled study, we found signiﬁcant increases
in attention to facial anger accompanied decreases in
self-reported depressive mood following 2-Hz rTMS
to the right parietal cortex in healthy volunteers
(van Honk et al. 2003). The subsequent intention-
to-treat double-blind, sham-controlled study in de-
pressed patient did not yield an overall diﬀerence in
therapeutic response between 10 sessions of real and
sham 2-Hz rTMS to the right parietal cortex (Schutter
et al. 2009). According to some researchers, clinical
improvement may not appear until several weeks fol-
lowing treatment onset (Harmer et al. 2009a ; Frazer &
Benmansour, 2002). In contrast, recent studies suggest
that mood improvements can already be observed
within 2 wk of starting of antidepressant treat-
ment (Katz et al. 2010; Nakajima et al. 2010). The
present data suggest that even though 2 wk of rTMS
treatment may be too short to obtain robust and clini-
cally relevant eﬀects, the change in sensitivity for
angry faces may, nonetheless, indicate onset of
antidepressant action. Even though the precise re-
lationship between the currently observed alteration
in perceptual sensitivity and antidepressant action
needs to be explored further, the increased sensitivity
for angry facial expressions may indicate continuation
of treatment.
Unfortunately, the hypothesized increase in the
sensitivity for happy facial expressions did not reach
signiﬁcance and was not correlated to the baseline-
corrected change in HAMD17 scores. There was in-
suﬃcient statistical power due to the relatively large
between-subject variance in the sham condition and
a ‘ﬂoor’ eﬀect resulting from the fact that happy
facial expressions are already recognized at very low
intensities (see Fig. 2). In addition, small sample size
and absence of a baseline measure on the recognition
sensitivity of emotional facial expressions stress the
preliminary nature of the present ﬁndings. Finally,
despite the sham-controlled design, success of treat-
ment blinding, the time delay between the ﬁnal treat-
ment and assessment, and the fact that the present
ﬁndings are in good agreement with other electro-
physiological and administration studies (Nakajima
et al. 2010; Savaskan et al. 2008; Schutter et al. 2001),
individual diﬀerences experienced in site pain or
general discomfort as a function of stimulation inten-
sity between real and sham rTMS conditions may
have inﬂuenced the results. Finally, a general (sub-
convulsive) modulatory eﬀect on the brain that is
independent of the cortical site being targeted may
provide another explanation for the present data
(Schutter, 2010).
In conclusion, increased sensitivity of angry facial
expressions after real compared to sham rTMS treat-
ment together with the correlation between the sensi-
tivity of angry facial expressions and percentage
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change in HAMD17 scores is in agreement with pre-
vious studies and provides the ﬁrst evidence in sup-
port of the cognitive neuropsychological hypothesis of
antidepressant action in rTMS treatment.
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